Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Koh received his medical degree in Singapore followed by all of his subsequent haematology training (MRCP, FRCPath) in London. He holds several joint positions as the Clinical Director of the Renal, Haematology and Oncology Directorate at St George's University Hospital as well as a Professor in the Infection and Immunity Clinical Academic Group of St George’s, University of London. He is also the Medical Director of the Cell Therapy Facility and Programme in Singapore, actively engaging in cell and gene therapy translational clinical trials and GMP manufacturing.

He obtained his PhD in the area of T cell immunotherapy in transplantation in 2000. His other roles are detailed below.

• Fellow: Royal College of Pathologists and Royal College of Physicians
• Executive board, Worldwide Network for Blood and Marrow Transplantation (WBMT)
• Chair: International Society of Blood Transfusion (ISBT), Cellular Therapy Working Party
• Vice-Chair: International Society of Cell Therapy (Unproven Cell Therapies Presidential Task Force)
• Scientific Board: Asian Pacific Bone Marrow Transplant (APBMT)
• Expert.Working group member: Alliance for the Harmonisation of Cell Therapy Accreditation(AHCTA) and Cell Therapy Coding and Labelling(CTCLAG)
• Editorial Board: Hematology / Oncology and Stem Cell Therapy Journal, Blood Cell Therapy, Therapeutic Radiation and Oncology, Advances in Cell and Gene Therapy
• Author and co-author of over 60 publications and book chapters

Mickey.Koh@stgeorges.nhs.uk

UK

Principal Investigators

BloodCounts!

Research Interest

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Internal Comments Only

Achievements